Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.
Forst, Thomas
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control. [electronic resource] - Experimental diabetes research 2012 - 635472 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1687-5303
10.1155/2012/635472 doi
Blood Glucose
Body Weight--drug effects
Diabetes Mellitus, Type 2--drug therapy
Diabetic Angiopathies--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--pharmacology
Endothelium, Vascular--drug effects
Glucagon-Like Peptide 1--agonists
Humans
Hypoglycemic Agents--pharmacology
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control. [electronic resource] - Experimental diabetes research 2012 - 635472 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1687-5303
10.1155/2012/635472 doi
Blood Glucose
Body Weight--drug effects
Diabetes Mellitus, Type 2--drug therapy
Diabetic Angiopathies--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--pharmacology
Endothelium, Vascular--drug effects
Glucagon-Like Peptide 1--agonists
Humans
Hypoglycemic Agents--pharmacology